These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13678797)

  • 1. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
    Holm R; Porter CJ; Edwards GA; Müllertz A; Kristensen HG; Charman WN
    Eur J Pharm Sci; 2003 Sep; 20(1):91-7. PubMed ID: 13678797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.
    Holm R; Porter CJ; Müllertz A; Kristensen HG; Charman WN
    Pharm Res; 2002 Sep; 19(9):1354-61. PubMed ID: 12403073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats.
    Holm R; Müllertz A; Christensen E; Høy CE; Kristensen HG
    Eur J Pharm Sci; 2001 Dec; 14(4):331-7. PubMed ID: 11684408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.
    Holm R; Müllertz A; Pedersen GP; Kristensen HG
    Pharm Res; 2001 Sep; 18(9):1299-304. PubMed ID: 11683243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
    Khoo SM; Shackleford DM; Porter CJ; Edwards GA; Charman WN
    Pharm Res; 2003 Sep; 20(9):1460-5. PubMed ID: 14567642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.
    Porter CJ; Charman SA; Charman WN
    J Pharm Sci; 1996 Apr; 85(4):351-6. PubMed ID: 8901067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.
    Trevaskis NL; Caliph SM; Nguyen G; Tso P; Charman WN; Porter CJ
    Pharm Res; 2013 Dec; 30(12):3254-70. PubMed ID: 23430484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
    Caliph SM; Charman WN; Porter CJ
    J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.
    Karpf DM; Holm R; Kristensen HG; Müllertz A
    Pharm Res; 2004 Aug; 21(8):1413-8. PubMed ID: 15359576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
    Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
    Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.
    Khoo SM; Edwards GA; Porter CJ; Charman WN
    J Pharm Sci; 2001 Oct; 90(10):1599-607. PubMed ID: 11745718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems.
    Liao H; Gao Y; Lian C; Zhang Y; Wang B; Yang Y; Ye J; Feng Y; Liu Y
    Int J Nanomedicine; 2019; 14():7291-7306. PubMed ID: 31564878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
    Thomas N; Holm R; Müllertz A; Rades T
    J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation.
    Patel MH; Sawant KK
    Eur J Pharm Sci; 2019 Oct; 138():105027. PubMed ID: 31377133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
    Porter CJ; Charman SA; Humberstone AJ; Charman WN
    J Pharm Sci; 1996 Apr; 85(4):357-61. PubMed ID: 8901068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
    Dokania S; Joshi AK
    Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Self-Microemulsifying Drug Delivery System to Improve Nisoldipine Bioavailability: Cell Line and In Vivo Evaluations : Development of Self-Microemulsifying Drug Delivery System.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    AAPS PharmSciTech; 2021 Oct; 22(8):256. PubMed ID: 34676456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.